Shimadzu’s new Nexera UC/s(SFC/UHPLC switching system) allows measurements by liquid chromatography (LC) and supercritical fluid chromatography (SFC) on a single system. Switching between SFC and LC enables rapid screening for optimum separation conditions resulting in improved analytical efficiency. Through a newly-released upgrade kit, UHPLC units already installed can be upgraded to the Nexera UC/s, thereby decreasing investment cost for the additional SFC system.
For more information please visit www.shimadzu.eu
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.